Diasorin SpA DSRLF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $84.12
- Day Range
- $88.21–88.21
- 52-Week Range
- $66.50–93.95
- Bid/Ask
- $55.33 / $115.67
- Shares Outstanding
- 49.27M
- Market Cap
- $4.42B
- Volume/Avg
- 2 / 140
Key Statistics
- Price/Earnings (Normalized)
- 25.10
- Price/Sales
- 3.45
- Dividend Yield (Trailing)
- 1.71%
- Dividend Yield (Forward)
- 1.71%
- Dividend Payment Schedule
- May
- Total Yield
- 10.73%
Company Profile
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment’s importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,260
- Website
- https://www.diasoringroup.com
Competitors
Valuation
|
Metric
|
DSRLF
|
BIO
|
BIM
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.10 | 39.20 | 16.22 |
Price/Book Value | 2.56 | 1.36 | 2.36 |
Price/Sales | 3.45 | 3.78 | 2.54 |
Price/Cash Flow | 16.75 | 26.39 | 11.52 |
Price/Earnings
DSRLF
BIO
BIM
Financial Strength
|
Metric
|
DSRLF
|
BIO
|
BIM
|
|---|---|---|---|
Quick Ratio | 0.81 | 2.14 | 1.44 |
Current Ratio | 1.79 | 3.14 | 2.30 |
Interest Coverage | 7.37 | 6.38 | 38.68 |
Quick Ratio
DSRLF
BIO
BIM
Profitability
|
Metric
|
DSRLF
|
BIO
|
BIM
|
|---|---|---|---|
Return on Assets (Normalized) | 7.09% | 2.47% | 9.12% |
Return on Equity (Normalized) | 13.48% | 3.53% | 12.43% |
Return on Invested Capital (Normalized) | 9.39% | 2.66% | 11.31% |
Return on Assets
DSRLF
BIO
BIM
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|P%FXWR& | LOCK|#f | $255B | |||
| Danaher Corp
DHR
| LOCK|L!zys>$z | LOCK|!!> | $161B | |||
| Agilent Technologies Inc
A
| LOCK|gW&?>&?< | LOCK|P% | $49B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|MxKMs$q | LOCK|k^ | $44B | |||
| IQVIA Holdings Inc
IQV
| LOCK|&%q>!> | LOCK|s%?n& | $44B | |||
| Waters Corp
WAT
| LOCK|%Y%>z&Y | LOCK|T&^ | $43B | |||
| Illumina Inc
ILMN
| LOCK|%r^!%D | LOCK|<gf% | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|C&&J>Xf | LOCK|DDkb | $33B | |||
| Quest Diagnostics Inc
DGX
| LOCK|Y&kq?$> | LOCK|D$S& | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|$v^B^sd | LOCK|trcmd | $26B |
United States